Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma

Equality Impact Assessment (Guidance development) (PDF 119 KB)

Final appraisal determination

Final appraisal determination document (PDF 448 KB)

Committee papers (PDF 3.21 MB)

Public committee slides (PDF 915 KB)

Draft guidance

Appraisal consultation document (PDF 432 KB)

Committee papers (PDF 27.9 MB)

Public committee slides (PDF 619 KB)

Equality Impact Assessment (Guidance development) (PDF 119 KB)

Final scope (PDF 105 KB)

Final matrix (PDF 97 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 191 KB)